Adient (NYSE:ADNT) Price Target Lowered to $19.00 at Morgan Stanley

Adient (NYSE:ADNT) had its price target decreased by Morgan Stanley from $21.00 to $19.00 in a research report released on Thursday,Benzinga reports. Morgan Stanley currently has an underweight rating on the stock.

A number of other research analysts have also recently weighed in on the stock. JPMorgan Chase & Co. lowered their target price on shares of Adient from $31.00 to $27.00 and set a “neutral” rating on the stock in a research note on Thursday, August 8th. Wolfe Research began coverage on Adient in a research report on Thursday, September 5th. They issued a “peer perform” rating on the stock. Barclays cut their target price on Adient from $29.00 to $24.00 and set an “equal weight” rating for the company in a research report on Thursday, August 8th. UBS Group lowered their price target on Adient from $27.00 to $24.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Finally, StockNews.com raised shares of Adient from a “hold” rating to a “buy” rating in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $25.13.

Adient Trading Down 2.5 %

NYSE:ADNT opened at $19.89 on Thursday. Adient has a one year low of $19.30 and a one year high of $37.19. The business has a fifty day moving average price of $21.32 and a 200-day moving average price of $23.84. The firm has a market capitalization of $1.73 billion, a price-to-earnings ratio of 86.48, a price-to-earnings-growth ratio of 0.46 and a beta of 2.18. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.11 and a quick ratio of 0.90.

Adient (NYSE:ADNT) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.56 by $0.12. The firm had revenue of $3.56 billion for the quarter, compared to the consensus estimate of $3.47 billion. Adient had a return on equity of 6.86% and a net margin of 0.12%. The business’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 earnings per share. Sell-side analysts forecast that Adient will post 2.27 EPS for the current year.

Hedge Funds Weigh In On Adient

Several institutional investors have recently bought and sold shares of ADNT. CWM LLC boosted its holdings in shares of Adient by 44.5% in the 2nd quarter. CWM LLC now owns 1,439 shares of the company’s stock worth $36,000 after purchasing an additional 443 shares during the period. US Bancorp DE boosted its stake in Adient by 583.8% during the third quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after buying an additional 1,588 shares during the period. Signaturefd LLC boosted its stake in Adient by 493.8% during the third quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock worth $49,000 after buying an additional 1,822 shares during the period. KBC Group NV increased its position in Adient by 51.8% during the third quarter. KBC Group NV now owns 3,328 shares of the company’s stock valued at $75,000 after acquiring an additional 1,136 shares during the last quarter. Finally, Covestor Ltd raised its stake in shares of Adient by 201.5% in the first quarter. Covestor Ltd now owns 3,307 shares of the company’s stock valued at $109,000 after acquiring an additional 2,210 shares during the period. Institutional investors own 92.44% of the company’s stock.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.